Synergy Clinical Trials

A Phase IIa Randomized, Double-Blind, Placebo-Controlled, 7-Day Repeat, Oral-Dose Study to Assess the Safety and Pharmacodynamic Effects of SP-304 in Patients with Chronic Idiopathic Constipation (CIC) – scheduled to open for enrollment in Q1 2010.